Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis.

Zeitler EP, Sanders GD, Singh K, Greenfield RA, Gillis AM, Wilkoff BL, Piccini JP, Al-Khatib SM.

Europace. 2018 Oct 1;20(10):1621-1629. doi: 10.1093/europace/euy183.

PMID:
30137296
2.

Cable externalization and electrical failure of the Riata family of implantable cardioverter-defibrillator leads: A systematic review and meta-analysis.

Zeitler EP, Pokorney SD, Zhou K, Lewis RK, Greenfield RA, Daubert JP, Matchar DB, Piccini JP.

Heart Rhythm. 2015 Jun;12(6):1233-40. doi: 10.1016/j.hrthm.2015.03.005. Epub 2015 May 18. Review.

PMID:
25998139
3.

Preprocedural ECG-gated computed tomography for prevention of complications during lead extraction.

Lewis RK, Pokorney SD, Greenfield RA, Hranitzky PM, Hegland DD, Schroder JN, Lin SS, Milano C, Daubert JP, Smith PK, Hurwitz LM, Piccini JP.

Pacing Clin Electrophysiol. 2014 Oct;37(10):1297-305. doi: 10.1111/pace.12485. Epub 2014 Sep 8.

PMID:
25195955
4.

Novel mechanism of premature battery failure due to lithium cluster formation in implantable cardioverter-defibrillators.

Pokorney SD, Greenfield RA, Atwater BD, Daubert JP, Piccini JP.

Heart Rhythm. 2014 Dec;11(12):2190-5. doi: 10.1016/j.hrthm.2014.07.038. Epub 2014 Jul 30.

PMID:
25086256
5.

Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections.

Krishnamoorthy A, Pokorney SD, Lewis RK, Daubert JP, Greenfield RA, Hegland DD, Milano CA, Rogers JG, Schroder JN, Patel CB, Piccini JP.

J Cardiovasc Electrophysiol. 2014 Nov;25(11):1199-205. doi: 10.1111/jce.12461. Epub 2014 Jul 8.

PMID:
24890850
6.

Laser lead extraction in congenital heart disease: a case-controlled study.

McCanta AC, Kong MH, Carboni MP, Greenfield RA, Hranitzky PM, Kanter RJ.

Pacing Clin Electrophysiol. 2013 Mar;36(3):372-80. doi: 10.1111/pace.12071. Epub 2013 Jan 10.

PMID:
23305443
7.

Case-control study of statin prevention of mould infections.

Thompson JN, Huycke MM, Greenfield RA, Kurdgelashvili G, Gentry CA.

Mycoses. 2011 Sep;54(5):e481-5. doi: 10.1111/j.1439-0507.2010.01957.x. Epub 2011 May 9.

PMID:
21554419
8.

Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis.

Bose P, Parekh HD, Holter JL, Greenfield RA.

J Clin Microbiol. 2011 Apr;49(4):1674-5. doi: 10.1128/JCM.02325-10. Epub 2011 Jan 26.

9.

Emerging pathogens and knowledge in infectious diseases.

Greenfield RA, Bronze MS.

Am J Med Sci. 2010 Sep;340(3):177-80. doi: 10.1097/MAJ.0b013e3181e937fe. No abstract available.

PMID:
20697260
10.

Tickborne infections in the southern United States.

Salinas LJ, Greenfield RA, Little SE, Voskuhl GW.

Am J Med Sci. 2010 Sep;340(3):194-201. doi: 10.1097/MAJ.0b013e3181e93817. Review.

PMID:
20697259
11.

Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease.

Blevins SM, Greenfield RA, Bronze MS.

Cleve Clin J Med. 2008 Jul;75(7):521-30. Review.

PMID:
18646588
12.

Fatal Thrombosis After Factor VII Administration During Extracorporeal Membrane Oxygenation.

Swaminathan M, Shaw AD, Greenfield RA, Grichnik KP.

J Cardiothorac Vasc Anesth. 2008 Apr;22(2):259-60. doi: 10.1053/j.jvca.2007.09.009. Epub 2007 Nov 26. No abstract available.

PMID:
18375330
13.

Gatifloxacin-associated hypoglycemia.

Ali T, Greenfield RA, Scofield H, Bronze MS.

J Okla State Med Assoc. 2007 Nov;100(11):425-8.

PMID:
18183859
14.

Part XV. Antiretroviral therapy for human immunodeficiency virus infection.

Stephens JR, Rathbun RC, Lockhart SM, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Nov;100(11):417-24. Review.

PMID:
18183858
15.

Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.

Lockhart SM, Salvaggio MR, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Oct;100(10):388-95.

PMID:
18085096
16.

Part XIII. Systemic antifungal therapy.

Busse KH, Gentry CA, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Sep;100(9):344-51. Review.

PMID:
18020039
17.

Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.

Sud B, Salvaggio M, Greenfield R, Bronze MS.

J Okla State Med Assoc. 2007 Jul;100(7):267-72. Review. No abstract available. Erratum in: J Okla State Med Assoc. 2007 Oct;100(10):405. Greenfield, Ronald A [corrected to Greenfield, Ronald].

PMID:
17896614
18.

Part IX. Quinolone antimicrobials.

Vincent S, Machado L, Cooper TW, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 May;100(5):149-56. Review. No abstract available.

PMID:
17557602
19.

Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases.

Lockhart SM, Rathbun RC, Stephens JR, Baker DL, Drevets DA, Greenfield RA, Salvaggio MR, Vincent S.

AIDS. 2007 Jun 19;21(10):1370-3.

PMID:
17545718
20.

Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.

Hoffman-Roberts HL, Obritsch MD, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Apr;100(4):105-11. Review. No abstract available.

PMID:
17476993
21.

Part VII. Macrolides, azalides, ketolides, lincosamides, and streptogramins.

Dang V, Nanda N, Cooper TW, Greenfield RA, Bronze MS.

J Okla State Med Assoc. 2007 Mar;100(3):75-81. Review.

PMID:
17432033
22.

Antimicrobial symposium. Part VI. Aminoglycosides and polymyxins.

Nanda N, Dang V, Cooper TW, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Feb;100(2):60-4. No abstract available.

PMID:
17393675
23.

Part V. Other beta-lactam antimicrobials.

Gibbs WJ, Cooper TW, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Jan;100(1):23-5. Review. No abstract available.

PMID:
17378498
24.

Antimicrobial symposium. Part IV. Cephalosporins.

Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2006 Dec;99(12):579-83. Review. No abstract available.

PMID:
17310925
25.

Part III. Penicillins.

Gibbs WJ, Cooper TW, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2006 Nov;99(11):551-6. Review. No abstract available.

PMID:
17191689
26.

Part II. Introduction to the beta-lactam antibiotics.

Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2006 Oct;99(10):516-20. Review. No abstract available.

PMID:
17125105
27.

Antimicrobial symposium. Part 1. Principles of antimicrobial therapy.

Greenfield RA, Cooper TW, Bronze MS.

J Okla State Med Assoc. 2006 Sep;99(9):474-9. Review. No abstract available.

PMID:
17087070
28.

Panniculitis: a presenting manifestation of disseminated histoplasmosis in a patient with rheumatoid arthritis.

Sawalha AH, Lutz BD, Chaudhary NA, Kern W, Harley JB, Greenfield RA.

J Clin Rheumatol. 2003 Aug;9(4):259-62.

PMID:
17041467
29.

Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.

Saxon LA, Greenfield RA, Crandall BG, Nydegger CC, Orlov M, VAN Genderen R.

J Cardiovasc Electrophysiol. 2006 May;17(5):520-5.

PMID:
16684026
30.

Infectious disease outbreaks in competitive sports: a review of the literature.

Turbeville SD, Cowan LD, Greenfield RA.

Am J Sports Med. 2006 Nov;34(11):1860-5. Epub 2006 Mar 27. Review.

PMID:
16567462
31.

Infectious Aortitis.

Foote EA, Postier RG, Greenfield RA, Bronze MS.

Curr Treat Options Cardiovasc Med. 2005 Jun;7(2):89-97.

PMID:
15935117
32.

Levels of L-selectin (CD62L) on human leukocytes in disseminated cryptococcosis with and without associated HIV-1 infection.

Jackson LA, Drevets DA, Dong ZM, Greenfield RA, Murphy JW.

J Infect Dis. 2005 Apr 15;191(8):1361-7. Epub 2005 Mar 14.

PMID:
15776384
33.

Invasion of the central nervous system by intracellular bacteria.

Drevets DA, Leenen PJ, Greenfield RA.

Clin Microbiol Rev. 2004 Apr;17(2):323-47. Review.

34.
35.

Terrorism symposium update and conclusion.

Bronze MS, Huycke MM, Greenfield RA.

J Okla State Med Assoc. 2003 Dec;96(12):575-8. Review. No abstract available.

PMID:
14965028
36.

Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents.

Greenfield RA, Bronze MS.

Drug Discov Today. 2003 Oct 1;8(19):881-8. Review.

PMID:
14554016
37.

Chemical agents as potential weapons of mass destruction.

Greenfield RA, Brown BR, Hutchins JB, Jackson R.

J Okla State Med Assoc. 2003 Jul;96(7):309-12. Review. No abstract available.

PMID:
12955975
38.

Preventive and therapeutic approaches to viral agents of bioterrorism.

Bronze MS, Greenfield RA.

Drug Discov Today. 2003 Aug 15;8(16):740-5. Review.

PMID:
12944096
39.

Agroterrorism.

Lutz BD, Greenfield RA.

J Okla State Med Assoc. 2003 Jun;96(6):259-63. No abstract available.

PMID:
12858816
40.

Other bacterial diseases as a potential consequence of bioterrorism: Q fever, brucellosis, glanders, and melioidosis.

Voskuhl GW, Cornea P, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2003 May;96(5):214-7. Review. No abstract available.

PMID:
12833721
41.

Use of the AutoCapture Pacing System with implantable defibrillator leads.

Marenco JP, Greenfield RA, Massumi A, Syed ZA, Mcintyre T, Hardage M, Link MS, Homoud MK, Estes M 3rd, Wang PJ.

Pacing Clin Electrophysiol. 2003 Jan;26(1P2):471-3.

PMID:
12687870
42.

Biological toxins as potential agents of bioterrorism.

Slater LN, Greenfield RA.

J Okla State Med Assoc. 2003 Feb;96(2):73-6. Review. No abstract available.

PMID:
12674908
43.

Therapeutic options for diseases due to potential viral agents of bioterrorism.

Bronze MS, Greenfield RA.

Curr Opin Investig Drugs. 2003 Feb;4(2):172-8. Review.

PMID:
12669378
44.

The potential role of viral pathogens as agents of bioterrorism.

Bronze MS, Voskuhl GW, Machado LJ, Greenfield RA.

J Okla State Med Assoc. 2003 Jan;96(1):29-33. No abstract available.

PMID:
12632851
45.

Influenza virus: natural disease and bioterrorism threat.

Lutz BD, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2003 Jan;96(1):27-8. No abstract available.

PMID:
12632850
46.

Anthrax.

Greenfield RA, Drevets DA, Gilmore MS.

J Okla State Med Assoc. 2002 Sep;95(9):587-91. No abstract available.

PMID:
12362648
47.

Symposium introduction: clinical aspects of terrorism.

Greenfield RA, Bronze MS.

J Okla State Med Assoc. 2002 Sep;95(9):583-6. No abstract available.

PMID:
12362647
48.

Unconventional biological threats and the molecular biological response to biological threats.

Greenfield RA, Lutz BD, Huycke MM, Gilmore MS.

Am J Med Sci. 2002 Jun;323(6):350-7. Review.

PMID:
12074489
49.

Microbiological, biological, and chemical weapons of warfare and terrorism.

Greenfield RA, Brown BR, Hutchins JB, Iandolo JJ, Jackson R, Slater LN, Bronze MS.

Am J Med Sci. 2002 Jun;323(6):326-40. Review.

PMID:
12074487
50.

Viral agents as biological weapons and agents of bioterrorism.

Bronze MS, Huycke MM, Machado LJ, Voskuhl GW, Greenfield RA.

Am J Med Sci. 2002 Jun;323(6):316-25. Review.

PMID:
12074486

Supplemental Content

Loading ...
Support Center